Matinas Biopharma Holdings, Inc

Historical 13F Holders

Symbol
MTNB
CUSIP
576810303
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 576810303 since 12/18/2024, largest first.

Filer % of Class Filed
Pembroke & Partners LLC 13D/A
10.0% 4/10/2025
Event 4/8/2025
Sanitam Partners LLC 13D/A
10.0% 8/13/2026
Event 6/10/2026
Lazar David E. 13G 9.8% 8/19/2025
Event 8/15/2025
Hezbay Holdings LLC 13G 9.5% 7/14/2026
Event 7/13/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
111 Equity Group 13D/A
3.6% 2/19/2025
Event 2/13/2025
Highbridge Capital Management LLC 13G/A 0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 25 325 k $199 k
2026 Q1 28 354 k $177 k
2025 Q4 30 442 k $260 k
2025 Q3 28 330 k $618 k
2025 Q2 26 276 k $254 k
2025 Q1 26 320 k $166 k
2024 Q4 23 370 k $194 k
2024 Q3 19 546 k $1.90 M